- Home
- LENZ vs MEG Comparison
LENZ vs MEG Comparison
Compare LENZ & MEG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LENZ
- MEG
- Stock Information
- Founded
- LENZ 2019
- MEG 2012
- Country
- LENZ United States
- MEG United States
- Employees
- LENZ N/A
- MEG N/A
- Industry
- LENZ Medicinal Chemicals and Botanical Products
- MEG Professional Services
- Sector
- LENZ Health Care
- MEG Consumer Discretionary
- Exchange
- LENZ Nasdaq
- MEG Nasdaq
- Market Cap
- LENZ 1.2B
- MEG 985.6M
- IPO Year
- LENZ 2021
- MEG 2020
- Fundamental
- Price
- LENZ $48.74
- MEG $28.35
- Analyst Decision
- LENZ Strong Buy
- MEG Buy
- Analyst Count
- LENZ 4
- MEG 6
- Target Price
- LENZ $49.75
- MEG $32.50
- AVG Volume (30 Days)
- LENZ 406.2K
- MEG 442.0K
- Earning Date
- LENZ 11-05-2025
- MEG 11-05-2025
- Dividend Yield
- LENZ N/A
- MEG N/A
- EPS Growth
- LENZ N/A
- MEG N/A
- EPS
- LENZ N/A
- MEG N/A
- Revenue
- LENZ $5,000,000.00
- MEG $780,122,000.00
- Revenue This Year
- LENZ N/A
- MEG $18.02
- Revenue Next Year
- LENZ $285.73
- MEG $3.50
- P/E Ratio
- LENZ N/A
- MEG N/A
- Revenue Growth
- LENZ N/A
- MEG 17.79
- 52 Week Low
- LENZ $16.54
- MEG $10.51
- 52 Week High
- LENZ $50.40
- MEG $32.00
- Technical
- Relative Strength Index (RSI)
- LENZ 70.59
- MEG 50.59
- Support Level
- LENZ $39.51
- MEG $26.42
- Resistance Level
- LENZ $50.40
- MEG $28.17
- Average True Range (ATR)
- LENZ 2.17
- MEG 1.10
- MACD
- LENZ 0.66
- MEG -0.22
- Stochastic Oscillator
- LENZ 84.76
- MEG 41.15
About LENZ LENZ Therapeutics Inc.
LENZ Therapeutics Inc is a late-stage biopharmaceutical company focused on developing and commercializing therapies to improve vision and developing ophthalmic pharmaceutical products.. Its initial focus is the treatment of presbyopia, the inevitable loss of near vision that impacts the daily lives of nearly all people over 45.
About MEG Montrose Environmental Group Inc.
Montrose Environmental Group Inc is an environmental services company. The firm's operating segments are Assessment, Permitting and Response, Measurement and Analysis, and Remediation and Reuse. Through its Assessment, Permitting, and Response segment, the company provides scientific advisory and consulting services to support environmental assessments, environmental emergency response, and environmental audits. Measurement and Analysis include test and analysis of air, water, and soil to determine concentrations of contaminants whereas, the Remediation and Reuse segment provide clients with engineering, design, implementation, operations and maintenance services, to treat contaminated water, remove contaminant or create biogas. United States Contributes the majority of geographic revenue.